• Home
  • Media Events
  • Department of Clinical Research Hosts Alumni Speak on the Future of Clinical Research in Healthcare Industry

Department of Clinical Research Hosts Alumni Speak on the Future of Clinical Research in Healthcare Industry

Published on: March 24, 2025

On March 24, 2025, the Department of Clinical Research at the Himalayan Institute of Medical Sciences (HIMS), Swami Rama Himalayan University, successfully organized an Alumni Speak session titled “Future of Clinical Research in Healthcare Industry.” The event featured accomplished alumni currently working in reputed organizations, who shared valuable insights on the evolving clinical research landscape.

The session was conducted by Ms. Taniya Sharma, Data Analyst at Translational Health Science and Technology Institute (THSTI), Faridabad; Ms. Kirti Tapraniya, Clinical Research Coordinator at Subodh Clinical Research, New Delhi; and Ms. Srishti and Ms. Yashasvi Pankaj, Clinical Research Associates at Panacea Biotec, New Delhi. The session aimed to acquaint current MSc Clinical Research students with the latest advancements, challenges, and opportunities in the field.

Key Highlights of the Lecture:

  • Emerging Trends: Adoption of Artificial Intelligence (AI) and Machine Learning (ML) in trial design and data analysis; rise of decentralized and virtual clinical trials; personalized medicine shaping research methodologies.
  • Regulatory & Ethical Considerations: Updates on evolving guidelines from regulatory bodies like FDA and EMA; ethical issues in patient recruitment and data privacy; emphasis on Good Clinical Practice (GCP) compliance.
  • Technological Innovations: Use of big data and real-world evidence; wearable devices and remote monitoring enhancing patient participation; blockchain technology ensuring secure and transparent data management.

An interactive Q&A session followed, with discussions on AI’s role in reducing trial costs, challenges in conducting trials in developing countries, and the future scope of clinical research in a post-COVID-19 world.

The session inspired participants to embrace continuous learning and adapt to the rapid technological advancements shaping clinical research. It highlighted the importance of digital transformation and patient-centric approaches in advancing healthcare outcomes.

A group photograph was taken to commemorate the successful completion of the Alumni Meet, celebrating the achievements of both alumni and students. The event also featured a proud moment as Dr. Nikku Yadav awarded degrees to deserving students.

Picture22
Picture23
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.